Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.150
-0.060 (-4.96%)
At close: Dec 5, 2025, 4:00 PM EST
1.170
+0.020 (1.74%)
After-hours: Dec 5, 2025, 7:56 PM EST
Canopy Growth Revenue
Canopy Growth had revenue of 66.68M CAD in the quarter ending September 30, 2025, with 5.86% growth. This brings the company's revenue in the last twelve months to 278.61M, down -0.67% year-over-year. In the fiscal year ending March 31, 2025, Canopy Growth had annual revenue of 269.00M, down -9.47%.
Revenue (ttm)
278.61M CAD
Revenue Growth
-0.67%
P/S Ratio
1.97
Revenue / Employee
290,218 CAD
Employees
960
Market Cap
394.94M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 269.00M | -28.15M | -9.47% |
| Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
| Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
| Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
| Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CGC News
- 1 day ago - Canopy Growth Launches Claybourne Gassers Liquid Diamonds All-In-One Vapes in Canada, Expanding Footprint in High-Growth Vape Segment - Business Wire
- 3 days ago - Canadian Cannabis Market Outlook for December 2025: Key Trends for Investors - MarijuanaStocks
- 17 days ago - Three Canadian Cannabis Stocks Worth Watching This Week - MarijuanaStocks
- 17 days ago - Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels - Business Wire
- 20 days ago - Investing in Cannabis: Three Leading Stocks to Watch This November - MarijuanaStocks
- 23 days ago - Cannabis Investing Insight: Here Is How To Invest In Marijuana Stocks - MarijuanaStocks
- 23 days ago - Canopy Growth Q2 Results - Improved Net Loss, But Risks Remain - Seeking Alpha
- 4 weeks ago - Canopy Growth Corporation (WEED:CA) Q2 2026 Earnings Call Transcript - Seeking Alpha